• Thursday, April 30, 2026 8:30 a.m.-5:00 p.m.

    The Evolution of Biopharmaceutics: Risk Assessment and Clinical Relevance

    Mark your calendars to attend a workshop on Role of In Vitro Dissolution Studies for Predictive Insight into In Vivo Performance and Biopharmaceutics Risk Mitigation. The workshop is...

  • Friday, May 1, 2026 8:30 a.m.-3:00 p.m.

    The Evolution of Biopharmaceutics: Risk Assessment and Clinical Relevance

    Mark your calendars to attend a workshop on Role of In Vitro Dissolution Studies for Predictive Insight into In Vivo Performance and Biopharmaceutics Risk Mitigation. The workshop is...

  • Thursday, May 7, 2026 8:00 a.m.-12:00 p.m.

    Optimizing Pregnancy Registries

    Workshop LocationFDA White Oak CampusBuilding 31, Conference Center, The Great Room (Room 1503)10903 New Hampshire Ave.Silver Spring, MD 20993 ​Organized ByCDER Office of New...

  • Friday, May 8, 2026 10:00 a.m.-12:00 p.m.

    Optimizing Pregnancy Registries

    ​Workshop LocationFDA White Oak CampusBuilding 31, Conference Center, The Great Room (Room 1503)10903 New Hampshire Ave.Silver Spring, MD 20993 ​Organized ByCDER Office of New...

  • Wednesday, June 24, 2026 8:00 a.m.-5:00 p.m.

    Shaping the Future of Pediatric Formulation Development

    Date: June 24-25, 2026 Time: 8 a.m.-5 p.m. Location: University of Maryland School of Pharmacy, 20 N. Pine Street, Baltimore, MD 21201 About the Event Recent progress and...

  • Thursday, June 25, 2026 8:00 a.m.-5:00 p.m.

    Shaping the Future of Pediatric Formulation Development

    Date: June 24-25, 2026 Time: 8 a.m.-5 p.m. Location: University of Maryland School of Pharmacy, 20 N. Pine Street, Baltimore, MD 21201 About the Event Recent progress and...


Top

April 2026

SU MO TU WE TH FR SA
29 30 31 1 2 3 4
5 6 7 8 9 10 11
12 13 14 15 16 17 18
19 20 21 22 23 24 25
26 27 28 29 30 1 2
Submit an Event
Previous

April 2026

Next
Sunday Monday Tuesday Wednesday Thursday Friday Saturday
29

30

8:30 a.m.-5:00 p.m. The Evolution of Biopharmaceutics: Risk Assessment and Clinical Relevance

31

1

2

3

4

5

6

7

8

9

10

11

12

13

14

15

16

17

18

19

20

21

22

23

24

25

26

27

28

29

30

8:30 a.m.-5:00 p.m. The Evolution of Biopharmaceutics: Risk Assessment and Clinical Relevance

1

2

  • Audience: